Browsing Tag
compounding pharmacies
2 posts
HIMS near 52-week low as FDA issues 30 GLP-1 warning letters
FDA sends 30 warning letters to GLP-1 compounders, targeting Hims & Hers Health (HIMS) as regulatory and legal pressure intensifies. Read what it means for investors and the sector.
Inside the Pete Pharma–FABRX deal: Can 3D printing finally scale in compounding pharmacies?
Pete Pharma partners with FABRX to bring 3D printing to U.S. compounding pharmacies—find out how this could transform personalized medication delivery.